- Home
- ESP vs ZURA Comparison
ESP vs ZURA Comparison
Compare ESP & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESP
- ZURA
- Stock Information
- Founded
- ESP 1928
- ZURA 2022
- Country
- ESP United States
- ZURA United States
- Employees
- ESP N/A
- ZURA N/A
- Industry
- ESP Industrial Machinery/Components
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ESP Technology
- ZURA Health Care
- Exchange
- ESP Nasdaq
- ZURA Nasdaq
- Market Cap
- ESP 84.1M
- ZURA 76.6M
- IPO Year
- ESP N/A
- ZURA N/A
- Fundamental
- Price
- ESP $36.76
- ZURA $1.01
- Analyst Decision
- ESP
- ZURA Buy
- Analyst Count
- ESP 0
- ZURA 7
- Target Price
- ESP N/A
- ZURA $14.33
- AVG Volume (30 Days)
- ESP 26.2K
- ZURA 520.6K
- Earning Date
- ESP 05-12-2025
- ZURA 05-08-2025
- Dividend Yield
- ESP 2.73%
- ZURA N/A
- EPS Growth
- ESP 39.20
- ZURA N/A
- EPS
- ESP 2.67
- ZURA N/A
- Revenue
- ESP $45,965,588.00
- ZURA N/A
- Revenue This Year
- ESP N/A
- ZURA N/A
- Revenue Next Year
- ESP N/A
- ZURA N/A
- P/E Ratio
- ESP $13.69
- ZURA N/A
- Revenue Growth
- ESP 29.60
- ZURA N/A
- 52 Week Low
- ESP $20.20
- ZURA $0.97
- 52 Week High
- ESP $39.41
- ZURA $5.56
- Technical
- Relative Strength Index (RSI)
- ESP 63.52
- ZURA 34.02
- Support Level
- ESP $34.90
- ZURA $0.99
- Resistance Level
- ESP $39.41
- ZURA $1.06
- Average True Range (ATR)
- ESP 1.41
- ZURA 0.08
- MACD
- ESP -0.04
- ZURA -0.01
- Stochastic Oscillator
- ESP 64.29
- ZURA 0.00
About ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.